Skip to main content
OpenTrials
Completed

NCT Number: NCT01230164

Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations

An aberrometer measures visual aberrations by mapping how light rays travel through the eye and by providing maps using colored gradients to represent the magnitude of refractive errors of the eye.

The purpose of this study is to compare 4 different aberrometers -Wavescan (Visx Technology), Zywave (Bausch & Lomb), Ladarwave aberrometer (Alcon Inc.) and Allegro Analyzer (Alcon Inc). In particular, the investigators propose to focus on the ability of these devices to display the higher order visual aberrations and to compare the quality of outputs from these 4 devices in normal healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, 02114, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male or female, at least 18 years of age
  • no ocular abnormality other than refractive error
  • patient in generally good & stable overall health
  • has not worn contact lenses (hard or gas permeable lenses for at least 3 weeks and soft lenses for at least 3 days) prior to the study exam
  • corneal topography must be normal, as judged by the investigator
  • topical anesthesia and mydriatics must be tolerated
  • patient must be able to fixate steadily
  • ability to understand and provide informed consent to participate in this study

Exclusion criteria

  • history of ocular surgery
  • history of ocular trauma, infection, disease, or abnormality other than refractive error
  • myopia or hyperopia > 7.0 D, astigmatism >3.0 D
  • uncorrectable visual acuity below 20/20
  • abnormal corneal topography pattern including, but not limited to keratoconus, forme fruste keratoconus, or corneal warpage
  • pupil sizes below 6.0 mm under mydriasis
  • iris problems including, but not limited to, coloboma and previous iris surgery
  • ocular media problems, corneal, lens and/or vitreous opacities including, but not limited to cataract
  • ocular movement abnormalities including, but not limited to, strabismus or nystagmus
  • phenol red thread test (Zone Quick-Menicon Ltd) less than 9 mm/15 seconds
  • pregnancy and lactation

Sponsors and collaborators

Lead sponsor

Massachusetts Eye and Ear Infirmary

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 28, 2010
Registry last updated
Dec 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.